[MOL] Some really good info. for most cancers.... [01224] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Some really good info. for most cancers....




> | HEMATOLOGY-ONCOLOGY TREATMENT UPDATES - MONOCLONAL ANTIBODIES IN THE
> | TREATMENT OF CANCER
> | An update on the clinical benefits and therapeutic indications of
> | monoclonal antibodies currently used for routine or experimental
treatment
> | of patients with non-Hodgkin's lymphoma and breast cancer.
> | Hematology-Oncology Treatment Updates - (C) 2000 Medscape, Inc.
> | http://oncology.medscape.com/24773.rhtml
> | <a href="http://oncology.medscape.com/24773.rhtml">Read it Here</a>
> |
> | CANCER RISK IN PERSONS WITH HIV/AIDS IN THE ERA OF COMBINATION
> | ANTIRETROVIRAL THERAPY
> | Which types of cancer occur at increased rates in patients with HIV and
> AIDS?
> | The AIDS Reader 10(6):341-346, 2000
> | http://oncology.medscape.com/24775.rhtml
> | <a href="http://oncology.medscape.com/24775.rhtml">Read it Here</a>
> |
> | GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: ASSOCIATION WITH A
NEW
> | HELICOBACTER SPECIES
> | Epidemiologic and clinical investigations have established a possible
link
> | between primary gastric mucosa-associated lymphoid tissue (MALT)
lymphoma
> | and chronic H. pylori infection.
> | Copyright (C) 1998, 1999, 2000 The McGraw-Hill Companies.
> | http://oncology.medscape.com/24618.rhtml
> | <a href="http://oncology.medscape.com/24618.rhtml">Read it Here</a>
> |
> | ASK THE EXPERTS - THE BEST TREATMENT FOR A T4 TRANSITIONAL BLADDER
CANCER?
> | What is the best therapeutic approach for transitional bladder cancer
with
> | invasion of the rectum without evidence of metastatic disease in a
> | previously healthy 61-year-old male?
> | http://oncology.medscape.com/24703.rhtml
> | <a href="http://oncology.medscape.com/24703.rhtml">Read it Here</a>
> |
> | ASK THE EXPERTS - SURGERY OR CHEMOTHERAPY FOR A T3 LARYNGEAL CANCER?
> | In stage T3N1M0 squamous cell carcinoma of the larynx, is the initial
use
> | of radiotherapy and chemotherapy -- with the provision to reconsider
> | surgery if the trial fails -- actually used and recommended?
> | http://oncology.medscape.com/24827.rhtml
> | <a href="http://oncology.medscape.com/24827.rhtml">Read it Here</a>
> |
> | GUEST EDITORIAL - THYROID CANCER IN THE NEW MILLENNIUM
> | The aftermath of the nuclear disaster at Chernobyl sensitized a large
> | proportion of the general public about not only the importance of
thyroid
> | cancer as a disease, but also the need to minimize radiation exposure of
> | children as a preventive measure.
> | Cancer Control; JMCC 7(3):209-210, 2000.
> | http://oncology.medscape.com/24560.rhtml
> | <a href="http://oncology.medscape.com/24560.rhtml">Read it Here</a>
> |
> | NEUROIMAGING CASE CHALLENGE - A 42-YEAR-OLD WOMAN WITH SEIZURES AND
MENTAL
> | STATUS CHANGE
> | What's your diagnosis?
> | Medscape Neurology, 2000
> | http://oncology.medscape.com/24724.rhtml
> | <a href="http://oncology.medscape.com/24724.rhtml">Read it Here</a>
> |
> | _______________________________________________________________________
> | ___________________________________ NEWS ______________________________
> |
> | ATOMIC BOMB SURVIVORS DO NOT LIVE LONGER THAN UNEXPOSED PEERS
> | Japanese survivors of the atomic bomb have their life expectancy reduced
> by
> | an average of about 4 months, which does not support claims that
survivors
> | exposed to low levels of radiation live longer than comparable unexposed
> | individuals.
> | http://oncology.medscape.com/24797.rhtml
> | <a href="http://oncology.medscape.com/24797.rhtml">Read it Here</a>
> |
> | COLONOSCOPY FAVORED FOR COLORECTAL CANCER SCREENING IN ASYMPTOMATIC
ADULTS
> | Colonoscopy should be used instead of sigmoidoscopy in screening for
> | colorectal cancer, according to two reports in the July 20th issue of
the
> | New England Journal of Medicine.
> | http://oncology.medscape.com/24725.rhtml
> | <a href="http://oncology.medscape.com/24725.rhtml">Read it Here</a>
> |
> | TESTICULAR CANCER TREATMENT: SURVIVAL ADVANTAGE OUTWEIGHS RISK OF
LEUKEMIA
> | Modern radiation and chemotherapy regimens for testicular cancer are
> | associated with only a small excess risk of leukemia, which is far
> | outweighed by the survival advantage that treatment confers, according
to
> a
> | multinational team of researchers.
> | http://oncology.medscape.com/24652.rhtml
> | <a href="http://oncology.medscape.com/24652.rhtml">Read it Here</a>
> |
> | COGNITIVE FUNCTION DECLINES IN BREAST CANCER PATIENTS UNDERGOING
> CHEMOTHERAPY
> | Women undergoing chemotherapy for breast cancer have significantly
reduced
> | cognitive function compared with healthy controls, according to a team
of
> | Canadian researchers.
> | http://oncology.medscape.com/24527.rhtml
> | <a href="http://oncology.medscape.com/24527.rhtml">Read it Here</a>
> |
> | SATISFACTION HIGH AFTER PROPHYLACTIC BILATERAL MASTECTOMY
> | Most women are satisfied after bilateral prophylactic mastectomy and
> report
> | much less concern about developing breast cancer, according to
researchers
> | at the Mayo Foundation and Mayo Clinic, in Rochester, Minnesota.
> | http://oncology.medscape.com/24653.rhtml
> | <a href="http://oncology.medscape.com/24653.rhtml">Read it Here</a>
> |
> | SURVIVAL SIMILAR AFTER MASTECTOMY, BREAST-CONSERVING THERAPY FOR STAGE
II
> | TUMORS
> | Breast-conserving therapy and radical mastectomy give similar survival
> | rates in women with breast tumors larger than 2 cm, according to a
report
> | in the July 19th issue of the Journal of the National Cancer Institute.
> | http://oncology.medscape.com/24658.rhtml
> | <a href="http://oncology.medscape.com/24658.rhtml">Read it Here</a>
> |
> | PATIENTS WITH SMALL BREAST CANCERS SHOULD HAVE AXILLA INVESTIGATED FOR
> | METASTASIS
> | Increasing tumor size, poor histologic grade, and younger age are
> | significant predictors of axillary lymph node metastasis (ALNM) in
> patients
> | with invasive breast cancers 1 cm or less.
> | http://oncology.medscape.com/24734.rhtml
> | <a href="http://oncology.medscape.com/24734.rhtml">Read it Here</a>
> |
> | STEM CELL TRANSPLANT MAY BE BEST CHOICE FOR SELECTED METASTATIC BREAST
> CANCERS
> | High-dose chemotherapy followed by hematopoietic stem cell
transplantation
> | has been found to be no more effective than standard therapy for most
> | breast cancers, but this aggressive regimen may still be the best
approach
> | in selected patients, according to Dr. Roy B. Jones of the University of
> | Colorado Cancer Center in Denver.
> | http://oncology.medscape.com/24664.rhtml
> | <a href="http://oncology.medscape.com/24664.rhtml">Read it Here</a>
> |
> | MAMMOGRAPHY MAY IDENTIFY WOMEN AT INCREASED RISK FOR CARDIOVASCULAR
> DISEASE
> | Breast artery calcium (BAC) seen on mammography is associated with
> | increased risk of atherosclerotic cardiovascular disease, according to
> | Israeli researchers.
> | http://oncology.medscape.com/24727.rhtml
> | <a href="http://oncology.medscape.com/24727.rhtml">Read it Here</a>
> |
> | GLANDULAR ATYPIA ON PAP TESTING WARRANTS AGGRESSIVE MANAGEMENT
> | The results of a community study carried out by US-based researchers
> | indicate that nearly half of patients with Pap smears classified as
> | containing atypical glandular cells of undetermined significance (AGUS)
> had
> | not undergone subsequent tissue biopsy.
> | http://oncology.medscape.com/24726.rhtml
> | <a href="http://oncology.medscape.com/24726.rhtml">Read it Here</a>
> |
> | MOST MELANOMA PATIENTS DETECT THEIR OWN CANCER
> | More than half of melanoma patients detect their own cancers, with a
> | minority of cases detected by a physician.
> | http://oncology.medscape.com/24528.rhtml
> | <a href="http://oncology.medscape.com/24528.rhtml">Read it Here</a>
> |
> | GENETICALLY MODIFIED TUMOR VACCINE SHOWS EFFECT IN LATE-STAGE MELANOMA
> | Preliminary results show that a genetically modified tumor vaccine can
> | produce responses in some patients with late-stage melanoma.
> | http://oncology.medscape.com/24668.rhtml
> | <a href="http://oncology.medscape.com/24668.rhtml">Read it Here</a>
> |
> | SKIN CANCER SURVEILLANCE ADVISED FOR KIDNEY TRANSPLANT RECIPIENTS
> | Strategies are needed to reduce the incidence of nonmelanoma skin
cancers
> | among renal transplant recipients, according to British researchers.
> | http://oncology.medscape.com/24572.rhtml
> | <a href="http://oncology.medscape.com/24572.rhtml">Read it Here</a>
> |
> | PACLITAXEL BLOCKS INVASION OF KAPOSI'S SARCOMA CELLS AND INTERFERES WITH
> | APOPTOSIS
> | The microtubule-stabilizing drug paclitaxel inhibits the growth of
> Kaposi's
> | sarcoma (KS) by blocking the growth, migration, and invasion of KS cells
> | and interfering with the expression of the antiapoptotic protein Bcl-2.
> | http://oncology.medscape.com/24605.rhtml
> | <a href="http://oncology.medscape.com/24605.rhtml">Read it Here</a>
> |
> | HEPARIN'S ANTI-TUMOR POTENTIAL SAID TO WARRANT CLINICAL TRIALS
> | The observation that heparin inhibits some kinds of tumors suggests that
> | the anticoagulant should be subjected to clinical trials as a
chemotherapy
> | agent, according to speakers at the 13th International Symposium on
> | Molecular Biology of Hematopoiesis and Treatment of Leukemia and Cancer.
> | http://oncology.medscape.com/24580.rhtml
> | <a href="http://oncology.medscape.com/24580.rhtml">Read it Here</a>
> |
> | THALIDOMIDE INDUCES RESPONSE IN LARGE SERIES OF MULTIPLE MYELOMA
PATIENTS
> | In the largest series of patients with refractory multiple myeloma
treated
> | with thalidomide that has been reported to date, 14% achieved a complete
> | response or nearly complete response, with almost 50% of patients still
> | alive after 2 years, according to Dr. Bart Barlogie of the University of
> | Arkansas for Medical Sciences, Little Rock.
> | http://oncology.medscape.com/24663.rhtml
> | <a href="http://oncology.medscape.com/24663.rhtml">Read it Here</a>
> |
> | 'MINI' TRANSPLANTS REPORTED EFFECTIVE FOR SOME HEMATOLOGIC MALIGNANCIES
> | Researchers from several institutions report that 'mini' transplants of
> | bone marrow or peripheral blood stem cells -- defined as transplants
> | without myeloablation and its sometimes fatal consequences -- can be
> | effective against a variety of hematologic malignancies, and may even
> prove
> | superior to conventional transplants.
> | http://oncology.medscape.com/24583.rhtml
> | <a href="http://oncology.medscape.com/24583.rhtml">Read it Here</a>
> |
> | G-CSF APPEARS BENEFICIAL WITH STEM CELL TRANSPLANTATION IN CHILDREN
> | Granulocyte colony stimulating factor (G-CSF, filgrastim) accelerates
> | neutrophil recovery in children who have received stem cell transplants
> for
> | the treatment of cancer.
> | http://oncology.medscape.com/24732.rhtml
> | <a href="http://oncology.medscape.com/24732.rhtml">Read it Here</a>
> |
> | FDA ADVISORY COMMITTEE RECOMMENDS GROUND RULES FOR STEM CELL PRODUCTS
> | At a meeting on Friday, the US Food and Drug Administration's (FDA)
> | Biological Response Modifiers Advisory Committee made several
> | recommendations about how the FDA should proceed in regulating the
> | development of stem cell-based products.
> | http://oncology.medscape.com/24554.rhtml
> | <a href="http://oncology.medscape.com/24554.rhtml">Read it Here</a>
> |
> | FDA WARNS OF SHORTAGES OF THREE DRUGS
> | Manufacturing problems have led to shortages or potential shortages of
> | Wyeth-Ayerst's Wydase, Roche's Romazicon and Faulding's Blenoxane,
> | according to the US Food and Drug Administration (FDA).
> | http://oncology.medscape.com/24602.rhtml
> | <a href="http://oncology.medscape.com/24602.rhtml">Read it Here</a>
> |
> | P53-EXPRESSING ADENOVIRUS GENE THERAPY CAUSES LYMPHOMA REGRESSION IN
MICE
> | Injection of an adenovirus that expresses p53 directly into the tumor
> | causes regression of established lymphomas in mice, according to
> scientists
> | in Des Moines, Iowa.
> | http://oncology.medscape.com/24559.rhtml
> | <a href="http://oncology.medscape.com/24559.rhtml">Read it Here</a>
> |
> | VACCINE BASED ON DENDRITIC CELLS APPEARS SAFE IN EARLY TRIALS OF
MULTIPLE
> | MYELOMA
> | A vaccine based on dendritic cells appears to be safe and may have some
> | effect in multiple myeloma and amyloidosis, according to a report at the
> | 13th International Symposium on Molecular Biology of Hematopoiesis and
> | Treatment of Leukemia, Lymphoma and Cancer.
> | http://oncology.medscape.com/24792.rhtml
> | <a href="http://oncology.medscape.com/24792.rhtml">Read it Here</a>
> |
> | AVAX LAUNCHES NEW SKIN CANCER VACCINE IN AUSTRALIA
> | AVAX Technologies Inc. on Tuesday said that it is selling a personalized
> | skin cancer vaccine in Australia, aimed at individuals whose melanoma
has
> | already spread.
> | http://oncology.medscape.com/24675.rhtml
> | <a href="http://oncology.medscape.com/24675.rhtml">Read it Here</a>
> |
> | CPG OLIGONUCLEOTIDES ENHANCE IMMUNOGENICITY OF TUMOR VACCINE IN MICE
> | Researchers at the Mayo Clinic have greatly enhanced the immunogenicity
of
> | protein-based melanoma vaccines in mice by repeatedly administering
> | synthetic oligonucleotides containing foreign
cytosine-phosphorothiolated
> | guanine (CpG) motifs.
> | http://oncology.medscape.com/24817.rhtml
> | <a href="http://oncology.medscape.com/24817.rhtml">Read it Here</a>
> |
> | CELL THERAPEUTICS' MYELODYSPLASTIC SYNDROMES DRUG RECEIVES ORPHAN DRUG
> STATUS
> | The US Food and Drug Administration (FDA) has granted orphan drug status
> to
> | Cell Therapeutics' anticancer drug treatment, Arsenic TriOxide (ATO),
for
> | the treatment of myelodysplastic syndromes, the Seattle-based company
said
> | on Tuesday.
> | http://oncology.medscape.com/24685.rhtml
> | <a href="http://oncology.medscape.com/24685.rhtml">Read it Here</a>
> |
> | ONYX, BAYER BEGIN CLINICAL TESTS OF POTENTIAL CANCER THERAPY
> | Onyx Pharmaceuticals and Bayer have begun phase I pharmacokinetic
clinical
> | testing of a ras pathway inhibitor that the companies hope will prove to
> be
> | an effective anticancer therapy, Richmond, California-based Onyx said on
> | Tuesday.
> | http://oncology.medscape.com/24670.rhtml
> | <a href="http://oncology.medscape.com/24670.rhtml">Read it Here</a>
> |
> | BOSTON HOSPITAL SUES ABBOTT OVER CANCER RESEARCH
> | A Boston research hospital countersued Abbott Laboratories Inc. on
> Tuesday,
> | claiming that the Chicago-based drug maker stole a formula for a
promising
> | cancer medicine.
> | http://oncology.medscape.com/24678.rhtml
> | <a href="http://oncology.medscape.com/24678.rhtml">Read it Here</a>
> |
> | EXPRESSION OF SOMATOSTATIN RECEPTOR REDUCES VOLUME OF PANCREATIC TUMORS
> | Expression of the somatostatin receptor sst2, followed by treatment with
a
> | cytotoxic somatostatin analog, inhibits growth of pancreatic cancers in
> | hamsters, according to a team of French and US researchers.
> | http://oncology.medscape.com/24606.rhtml
> | <a href="http://oncology.medscape.com/24606.rhtml">Read it Here</a>
> |
> | BRCA1 PART OF A COMPLEX THAT REGULATES CHROMATIN ACCESS
> | Scientists have found that the breast cancer susceptibility gene BRCA1
> | interacts with a protein complex that regulates access to DNA, providing
a
> | major clue to how alterations in the gene might lead to breast and
ovarian
> | cancer.
> | http://oncology.medscape.com/24818.rhtml
> | <a href="http://oncology.medscape.com/24818.rhtml">Read it Here</a>


------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------